Picture of two a poster presentation at an event and the words News and Events
James Moon
Boosting immunity: How James Moon and U-M are transforming cancer care
April 21, 2026

“Because our immune system is designed to protect against pathogens, we believe we can utilize our immune system to fight against many other diseases, including cancer. So my lab has been using drugs, as well as dietary fibers that can boost immune responses against various diseases, including cancer.”

Read Story
Carlos Aguilar
Carlos Aguilar Named to AIMBE College of Fellows
April 13, 2026

Congratulations, Dr. Carlos Aguilar, on being named to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE). Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to medical and biological engineers, comprised of the top two percent of engineers in these fields.

Read Story
Machine learning-driven single-cell phenotyping in size-controlled microenvironments via parallel deterministic droplet microfluidics
March 20, 2026

New Exciting Paper from BI Core Faculty, Dr. Jae-Won Shin.

“We present an integrated platform that combines parallel deterministic single-cell encapsulation acrossmultiple microgel sizes with machine-learning analysis of cell morphology, revealing size-dependentphenotypes and enabling prediction of microenvironmental confinement.”

Read the Paper
Nanoparticles
U-M BME Researchers Develop Nanoparticle Therapy to Boost the Immune System’s Attack on Metastatic Cancer
January 22, 2026

Researchers at U-M Biomedical Engineering, led by Lonnie Shea, Steven A. Goldstein Collegiate Professor, Biomedical Engineering, Ph.D. student Kate Griffin, and Jeff Ma, Ph.D., have published a study in Cell Biomaterials revealing a new approach to treating metastatic cancer using specially designed nanoparticles. This innovation could mark a major turning point in how metastatic cancers are treated in the future.

Read Story
Technology used to perform histotripsy, a revolutionary non-invasive cancer treatment recently made available for the first time in West Michigan, at the University of Michigan Health-West Professional Building in Wyoming
University of Michigan opens brain-computer interface clinic in Ann Arbor
January 6, 2026

“At the University of Michigan, we want to be focused on not just for our specific patients but for people in Michigan. We want to be focused on bringing people the most up to date clinical trials, the latest technology, so that it can be available to people.” Dr. Matthew Willsey

Read Story
Cindy Chestek
Michigan Research – December 2025: From Discovery to Real-World Impact
December 18, 2025

The December 2025 Michigan Research newsletter highlights how U-M researchers are turning bold ideas into real-world solutions. Featured work includes Cindy Chestek’s groundbreaking research on thought-controlled prosthetics, alongside advances in AI-enabled healthcare, interdisciplinary science, and innovation that directly improves lives.

Read Story
Sunitha Nagrath
A Blood Test That Shows If Brain Cancer Treatment Is Working
December 16, 2025

“There are tiny particles floating in patient blood, called extracellular vesicles, that have been released by the cancer cells. The big challenge is figuring out how to find and pull out only those that come from cancer cells and not from elsewhere in the body,” – Dr. Sunitha Nagrath

Read Story
Sunitha Nagrath
Dr. Sunitha Nagrath Appointed Dwight F. Benton Professor of Chemical Engineering
December 11, 2025

We are thrilled to announce that Dr. Sunitha Nagrath has been named the Dwight F. Benton Professor of Chemical Engineering!

In celebration of Dr. Nagrath’s innovative leadership in microfluidics and cancer diagnostics, and her dedication to translating engineering breakthroughs into tools that improve patient care. Her lab’s “smart chips” can isolate and analyze rare circulating tumor cells. A major stride in cancer research and diagnostics.

Read Story
Researchers Shine New Light on the Complex Nature of Rituximab
December 10, 2025

A new study just revealed not all batches of Rituximab (Rituxan®) are created equal. These findings highlight how critical rigorous quality control and careful characterization are for biologic medicines

Read Story
James Moon
Twenty-Nine U-M College of Pharmacy Faculty Among the World’s Top 2% of Scientists
December 3, 2025

Congratulations to Dr. James Moon, Dr. Steven Schwendeman, Dr. Anna Schwendeman, Dr. Guizhi (Julian) Zhu, and Dr. Peter Tessier on being named as apart of 2025’s World’s Top 2% Scientists Network!

Their continued impact on the scientific community is inspiring!

Read Story
Dr. James Moon, Dr. Steven Schwendeman, Dr. Anna Schwendeman, Dr. Guizhi (Julian) Zhu, and Dr. Peter Tessier
Celebrating U-M College of Pharmacy Leaders in Global Research: Moon, Schwendemans, Zhu & Tessier Recognized in Top 2%
December 3, 2025

Congratulations to Dr. James Moon, Dr. Steven Schwendeman, Dr. Anna Schwendeman, Dr. Guizhi (Julian) Zhu, and Dr. Peter Tessier on being named as apart of 2025’s World’s Top 2% Scientists Network!

Their continued impact on the scientific community is inspiring!

Read Story
Deepak Nagrath
Digital-Twin Models Bring Patient-Level Metabolic Flux Analysis to Brain Cancer
December 1, 2025

A new study by the Deepak Nagrath lab unveils two machine-learning, powered frameworks that estimate metabolic fluxes directly in brain-cancer patients, a major advance over prior studies limited to preclinical models.

Read Story
Peter Tessier
Hijacking the Brain’s Highways for Better Therapies
November 20, 2025

“We want to inject large molecules — proteins, peptides, nucleic acids — into the bloodstream and have them cross the blood-brain barrier in an efficient and predictable way to get them into the brain interior,” – Dr. Peter Tessier

Read Story
Colin Greineder
A New Era for Bone Health Begins, Dr. Greineder’s Latest Venture
November 17, 2025

Skeletalis is now live, driven by Colin Greineder and his fellow cofounders’ pioneering work in bone-targeted therapeutics.

Osteoporosis affects over 10 million adults in the U.S., yet current treatments still fall short. Their team is rethinking how osteoporosis drugs interact with bone, aiming for safer, more durable therapies that truly meet patient needs.

This is the future of skeletal health, and they’re building it now.

 

Read Story
Lonnie Shea
U-M Awards New Commercialization Fellowships: Including Shea Lab Innovator
November 14, 2025

Among the awardees is Brian Ross (PI: Lonnie Shea lab), whose work on advanced cell-capture scaffolding is advancing toward real-world impact under the startup Porosity Bio.

Read Story

The Biointerfaces Institute brings extensive experience to the collaborations that lead to scientific breakthroughs, successful translation, and advanced learning.

Contact Us